<DOC>
	<DOCNO>NCT01067417</DOCNO>
	<brief_summary>The purpose pilot study find take hydroxychloroquine decrease immune activation ( stimulation body 's defence system ) people early HIV infection . Hydroxychloroquine medicine use successfully many year treat autoimmune disease ( disease immune system cause damage body ) , e.g . lupus rheumatoid arthritis . It generally safe long-term use easily accessible . The immune system stimulate response infection include HIV , treatment decrease immune activation may long-term clinical benefit i.e . delay onset treatment .</brief_summary>
	<brief_title>Evaluation Efficacy Hydroxychloroquine Decreasing Immune Activation Asymptomatic HIV-infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>1 . Documented HIV infection ELISA confirmatory test . 2 . Age 18 65 year . 3 . Naïve antiretroviral therapy ART least 12 month prior study entry . 4 . CD4 Tcell count great 400 cells/µL screen blood test one test perform within 6 month prior screen . 5 . Plasma HIV RNA viral load great 1000 copies/ml screen blood test 6 . Willing able provide write informed consent . 1 . History psoriasis , porphyria cutanea tarda , epilepsy , myasthenia gravis , myopathy cause , cardiac arrhythmia , glucose 6phosphate dehydrogenase ( G6PD ) deficiency . 2 . Insulindependent noninsulindependent diabetes mellitus . 3 . Chronic liver disease cause alcoholism . 4 . Primary HIV infection within 12 month prior screen , either confirm ( previous negative HIV antibody test within 12 month ) , suspect ( symptom strongly suggestive HIV seroconversion illness within previous 12 month patient know HIV antibody positive prior illness ) . 5 . Pneumonia , meningitis , septicaemia serious infection 2 month prior screen . 6 . Any acute infection fever systemic symptom within last 24 hour . 7 . Any vaccination 2 month prior screen . 8 . Active malignancy ( patient eligible treatment malignancy complete 2 year prior screen subsequent clinical evidence active disease ) active immunemediated inflammatory disease . 9 . Any known suicide attempt ( time past ) current past history depression require treatment within 2 year prior screen . Patients depression previous 2 year depression past may include , opinion physician , nature past episode depression patient 's current psychological state indicate risk recurrence depression trial likely low . Patients receive antidepressant medication reason symptomatic depression include trial . 10 . A woman currently pregnant breastfeeding . 11 . A woman childbearing potential planning become pregnant course study , unwilling take adequate contraception ( include barrier contraception ) throughout course study . 12 . Use systemic corticosteroid immunomodulatory drug within 12 month prior screen . 13 . Current use medication know serious hepatotoxic effect know interaction hydroxychloroquine . 14 . Evidence cardiac conduction defect cardiac arrhythmia screen ECG . 15 . Retinopathy visual field change detect screen eye examination . 16 . Hepatitis B surface antigen ( HBsAg ) positive Hepatitis C PCR positive ( patient Hepatitis C antibody positive allow participate provide PCR negative ) . 17 . Any following laboratory abnormality screen blood test : Haemoglobin le 10.5g/dl , Absolute neutrophil count le 1.0x109/L Platelet count le 100 X 109/L ALT AST , alkaline phosphatase 2.5 x upper limit normal ( ULN ) Serum creatinine great 1.5xULN Estimated creatinine clearance ( CockcroftGault equation* ) 60ml/min 18 . Inability attend comply treatment followup scheduling . 19 . Current participation clinical intervention trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Hydroxychloroquine</keyword>
	<keyword>Chloroquine</keyword>
	<keyword>HIV Infection</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Immune Activation</keyword>
	<keyword>inflammation</keyword>
	<keyword>treatment naive</keyword>
	<keyword>disease progression</keyword>
</DOC>